Indirect Estimation of the Comparative Treatment Effect in Pharmacogenomic Subgroups

Evidence of clinical utility is a key issue in translating pharmacogenomics into clinical practice. Appropriately designed randomized controlled trials generally provide the most robust evidence of the clinical utility, but often only data from a pharmacogenomic association study are available. This...

Descripción completa

Detalles Bibliográficos
Autores principales: Sorich, Michael J., Coory, Michael, Pekarsky, Brita A. K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3754999/
https://www.ncbi.nlm.nih.gov/pubmed/24015225
http://dx.doi.org/10.1371/journal.pone.0072256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3754999/
https://www.ncbi.nlm.nih.gov/pubmed/24015225
http://dx.doi.org/10.1371/journal.pone.0072256

Ejemplares similares